首页> 外文OA文献 >Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer
【2h】

Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer

机译:完善卵巢癌测试准确性评分(ROCkeTS):一项前瞻性纵向测试准确性研究的方案,以验证具有可疑卵巢癌症状的女性的新风险评分

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ovarian cancer (OC) is associated with non-specific symptoms such as bloating, making accurate diagnosis challenging: only 1 in 3 women with OC presents through primary care referral. National Institute for Health and Care Excellence guidelines recommends sequential testing with CA125 and routine ultrasound in primary care. However, these diagnostic tests have limited sensitivity or specificity. Improving accurate triage in women with vague symptoms is likely to improve mortality by streamlining referral and care pathways. The Refining Ovarian Cancer Test Accuracy Scores (ROCkeTS; HTA 13/13/01) project will derive and validate new tests/risk prediction models that estimate the probability of having OC in women with symptoms. This protocol refers to the prospective study only (phase III).
机译:卵巢癌(OC)与诸如腹胀之类的非特异性症状相关,这使得准确诊断具有挑战性:三分之一的OC妇女通过初级保健转诊就诊。美国国立卫生与医疗研究院卓越指南建议在基层医疗中使用CA125和常规超声进行顺序测试。但是,这些诊断测试的敏感性或特异性有限。症状模糊的妇女提高准确的分诊有可能通过简化转诊和护理途径来提高死亡率。精炼卵巢癌测试准确性评分(ROCkeTS; HTA 13/13/01)项目将推导并验证新的测试/风险预测模型,这些模型可估计有症状女性患有OC的可能性。该方案仅涉及前瞻性研究(第三阶段)。

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号